Aspira Pathlab & Diagnostics L Share Price

Aspira Pathlab & Diagnostics L Share Price

BSE: 540788
|
Healthcare Services
|
S Cap
₹ 126.78
+₹6.03 (4.99%)
1D
Last updated 22 Sep, 2026, 14:58 IST

Aspira Pathlab & Diagnostics L Share Price Today

As of 23 Sep 2026, Aspira Pathlab & Diagnostics L share price is ₹126.78. The stock opened at ₹126.78, compared to its previous close of ₹120.75. During today's trading session, Aspira Pathlab & Diagnostics L share price moved in the range of ₹126.78 to ₹126.78, with an average price of ₹126.78 for the day. Looking at its last 52-week, the stock has touched a low of ₹49.00 and a high of ₹135.88.

₹126.78
4.99% up today
₹126.78
1D LOW
1D HIGH

Aspira Pathlab & Diagnostics L Returns Calculator

Circuit
L
H
₹120.45
₹133.11
52-week
L
H
₹49.00
₹135.88

About Aspira Pathlab & Diagnostics L

Aspira Pathlab & Diagnostics L Share Price
ISIN
INE500C01017
Sector Market Cap
₹ 130.49 Cr

Aspira Pathlab & Diagnostics Limited is an India-based company, which is engaged in the business of running, owning, managing, and administering Diagnostics Centers. The principal activities of the Company consist of pathology investigation services, radiology investigation services and other related healthcare services at diagnostic centers in Mumbai. The Company carries out pathological investigations in various branches, including biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The Company's tests include pathology test, sonography, x-ray, and radiology. Its pathology tests include Influenza (Flu) Panel with H3N2, Blood chromosome analysis, Filmarray multiplex PCR(BIOFIRE) Pneumonia Panel Plus, Polycystic Ovarian Syndrome (PCOS) 2, Typhoid PCR, Dengue-Chikungunya-Malaria multiplex PCR, Vitamin And TSH, Fever screening profile-2, and others.

Aspira Pathlab & Diagnostics L Financial Highlights

  • Revenue: Aspira Pathlab & Diagnostics L reported revenue of ₹22.39 crore in FY25 vs ₹13.62 crore in FY24. It showed an increase of 64.39% on a yearly basis.
  • Operating Profit: Aspira Pathlab & Diagnostics L reported an operating profit of ₹2.02 crore in FY25 vs ₹2.67 crore in FY24. It showed an increase of 175.66% on a year-on-year basis.
  • Net Profit: Aspira Pathlab & Diagnostics L reported a net profit of ₹2.02 crore in FY25 vs ₹2.67 crore in FY24. It showed an increase of 175.66% on a yearly basis.

Aspira Pathlab & Diagnostics L Quarterly Result Highlights

  • Aspira Pathlab & Diagnostics L reported revenue of ₹5.36 crore in Jun 2025, compared with ₹5.91 crore in Mar 2025, representing a decrease of 9.31% on a quarter-on-quarter (QoQ) basis.
  • Aspira Pathlab & Diagnostics L reported an operating profit of ₹0.42 crore in Jun 2025, compared with ₹0.68 crore in Mar 2025, representing a decrease of 38.24% on a quarter-on-quarter (QoQ) basis.
  • Aspira Pathlab & Diagnostics L reported a profit of ₹0.42 crore in Jun 2025, compared with ₹0.68 crore in Mar 2025, reflecting a decrease of 38.24% on a QoQ basis.
  • The earnings per share (EPS) of Aspira Pathlab & Diagnostics L stood at ₹1.97 during Jun 2025.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
46.58%
FII
0.00%
Other DII
0.00%
Retail and other
53.42%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
124.29
P/E
54.41
P/B
18.03
ROE
16.62%
D/E
0.27
ROCE
13.17%
Div. Yield
0.00%
EPS(TTM)
0.05
Turnover
1.40
EV/EBITDA
31.99
Net Margin
0.00%
Op. Margin
0.00%
ROA
13.75%
Quick Ratio
0.00
Curr. Ratio
1.98
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Aspira Pathlab outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Aspira Pathlab appears to be fairly valued compared to its peers
Step 3 of 5
Earnings
Neutral
Aspira Pathlab earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Apollo Hospitals1,27,792.0058.8413.4820.48%0.3217.27%692.920.23%0.66103.81
Max Healthcare1,03,609.0070.749.5913.42%0.0912.97%91.840.19%0.277.37
MANIPAL HEALTH ENTERPRI L98,225.80108.315.9810.59%0.009.51%100.510.00%0.000.00
Fortis Healthcare67,512.1063.066.8210.53%0.2312.56%122.240.11%0.153.05
Aster DM Healthcare65,937.70180.6115.578.48%0.3110.10%49.230.24%0.435.20
Global Health40,523.0072.4210.1014.05%0.0615.26%149.240.03%0.7318.46
Narayana Hrudayalaya38,754.0047.128.4817.76%0.7611.42%127.100.24%0.7624.77
KRISHNA INST OF MED SCI L33,159.50170.728.8610.74%0.637.99%93.540.00%0.426.52
Dr. Lal Path Labs32,164.9058.7112.7920.13%0.0825.56%147.341.07%0.9130.45
Poly Medicure17,223.8055.055.5510.37%0.0812.71%301.170.21%0.4833.15

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Aspira Pathlab & Diagnostics L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Revenue₹22.00₹13.20
Other Income₹0.39₹0.42
Total Revenue₹22.39₹13.63
Total Expenses₹20.32₹16.30
Profit Before Tax₹2.02-₹2.67
Tax₹0.00₹0.00
Profit After Tax₹2.02-₹2.67
EPS - Basic₹1.97-₹2.60
EPS - Diluted₹1.97-₹2.60

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Profit before tax₹2.02-₹2.67
Income before WC changes₹3.80-₹0.90
Change in Assets-₹2.29₹1.45
Change in Liabilities₹0.32₹0.51
Change in WC-₹1.97₹1.96
Cash flow from Operations₹1.83₹1.05
Cash flow from Investing₹0.12₹0.14
Cash flow from Financing-₹0.99-₹0.95
Total Cash Flow₹0.95₹0.24
Cash (Start of the year)₹0.80₹0.57
Cash (End of the year)₹1.75₹0.80

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Non-Current Assets₹12.10₹10.35
Current Assets₹5.36₹4.36
Total Assets₹17.46₹14.71
Current Liabilities₹2.37₹2.07
Net Current Asset₹2.99₹2.28
Non-Current Liabilities₹2.92₹2.50
Equity Capital₹12.17₹10.14
Total Equity & Liabilities₹17.46₹14.71

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹22.00₹13.20₹14.46₹19.54
Other Income₹0.39₹0.42₹0.32₹0.09
Total Revenue₹22.39₹13.63₹14.78₹19.64
Total Expenses₹20.32₹16.30₹14.87₹15.18
Profit Before Tax₹2.07-₹2.67-₹0.09₹4.46
Tax₹0.00₹0.00₹0.00₹0.00
Profit After Tax₹2.07-₹2.67-₹0.09₹4.46
EPS - Basic₹2.01-₹2.60-₹0.09₹4.33
EPS - Diluted₹2.01-₹2.60-₹0.09₹4.33

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹2.07-₹2.67-₹0.09₹4.46
Income before WC changes₹3.85-₹0.90₹1.71₹6.86
Change in Assets-₹2.29₹1.45-₹1.59-₹4.87
Change in Liabilities₹0.32₹0.51-₹0.14₹0.05
Change in WC-₹1.97₹1.96-₹1.73-₹4.83
Cash flow from Operations₹1.88₹1.05-₹0.01₹2.03
Cash flow from Investing₹0.07₹0.14₹0.16-₹0.51
Cash flow from Financing-₹0.99-₹0.95-₹0.94-₹1.35
Total Cash Flow₹0.95₹0.24-₹0.79₹0.17
Cash (Start of the year)₹0.80₹0.57₹1.35₹1.19
Cash (End of the year)₹1.75₹0.80₹0.57₹1.35

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹12.15₹10.35₹11.49₹10.99
Current Assets₹5.36₹4.36₹5.86₹7.14
Total Assets₹17.51₹14.71₹17.34₹18.14
Current Liabilities₹2.37₹2.07₹1.58₹1.79
Net Current Asset₹2.99₹2.28₹4.27₹5.36
Non-Current Liabilities₹2.92₹2.50₹3.01₹3.56
Equity Capital₹12.22₹10.14₹12.75₹12.79
Total Equity & Liabilities₹17.51₹14.71₹17.34₹18.14
* All values are in INR Crore
Qty
Bid
915
126.78
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 915
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
5
Neutral
1
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
78.51
Bullish
ATR (14)
4.93
Neutral
STOCH(9,6)
100
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
34.38
Bearish
UO(9)
91.45
Bearish
ROC(12)
36.32
Bullish
WillR(14)
0
Bearish
Period
Simple value
Exponential vaue
5D
115.28
116.51
10D
105.52
109.38
20D
98.78
103.84
50D
100.42
101.95
100D
104.78
98.01
Volume trend — traded volume by day
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
16 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Aspira Pathlab & Diagnostics L Share Price
Aspira Pathlab & Diagnostics L
Healthcare Services
Add Stock
Add Another

Aspira Pathlab & Diagnostics L Share Price FAQs

Aspira Pathlab & Diagnostics L share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837